Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients

R Calati, C Crisafulli, M Balestri, A Serretti… - Progress in Neuro …, 2013 - Elsevier
Treatment resistant depression (TRD) is a significant clinical and public health problem.
Among others, neuroplasticity and inflammatory pathways seem to play a crucial role in the …
被引用次数：52 相关文章

Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.

R Calati, C Crisafulli, M Balestri, A Serretti… - PROGRESS IN NEURO …, 2013 - cris.unibo.it
Treatment resistant depression (TRD) is a significant clinical and public health problem.
Among others, neuroplasticity and inflammatory pathways seem to play a crucial role in the …

Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.

R Calati, C Crisafulli, M Balestri, A Serretti… - Progress in Neuro …, 2013 - psycnet.apa.org
Abstract [Correction Notice: An Erratum for this article was reported in Vol 46 of Progress in
Neuro-Psychopharmacology & Biological Psychiatry (see record 2013-32453-012). In the …

Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients

R Calati, C Crisafulli, M Balestri, A Serretti… - … & Biological Psychiatry, 2013 - infona.pl
Treatment resistant depression (TRD) is a significant clinical and public health problem.
Among others, neuroplasticity and inflammatory pathways seem to play a crucial role in the …

Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.

R Calati, C Crisafulli, M Balestri, A Serretti… - PROGRESS IN NEURO …, 2013 - iris.unime.it
Treatment resistant depression (TRD) is a significant clinical and public health problem.
Among others, neuroplasticity and inflammatory pathways seem to play a crucial role in the …

[引用][C] Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.

R Calati, C Crisafulli, M Balestri, A Serretti… - Progress in neuro …, 2013 - difusion.ulb.ac.be

Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.

R Calati, C Crisafulli, M Balestri, A Serretti… - Progress in Neuro …, 2013 - europepmc.org
Treatment resistant depression (TRD) is a significant clinical and public health problem.
Among others, neuroplasticity and inflammatory pathways seem to play a crucial role in the …

[引用][C] Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients

R CALATI, C CRISAFULLI, D AMITA… - Progress in neuro …, 2013 - pascal-francis.inist.fr
Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance,
response and remission in mood disorder patients CNRS Inist Pascal-Francis CNRS Pascal …

Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients

R Calati, C Crisafulli, M Balestri, A Serretti… - PROGRESS IN …, 2013 - boa.unimib.it
Abstract Treatment resistant depression (TRD) is a significant clinical and public health
problem. Among others, neuroplasticity and inflammatory pathways seem to play a crucial …

Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients

R Calati, C Crisafulli, M Balestri… - Progress in neuro …, 2013 - pubmed.ncbi.nlm.nih.gov
Treatment resistant depression (TRD) is a significant clinical and public health problem.
Among others, neuroplasticity and inflammatory pathways seem to play a crucial role in the …